These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9001822)

  • 1. Treatment regimens for patients with toxoplasmic encephalitis.
    Fung HB; Kirschenbaum HL
    Clin Ther; 1996; 18(6):1037-56; discussion 1036. PubMed ID: 9001822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group.
    Podzamczer D; Miró JM; Bolao F; Gatell JM; Cosín J; Sirera G; Domingo P; Laguna F; Santamaría J; Verdejo J
    Ann Intern Med; 1995 Aug; 123(3):175-80. PubMed ID: 7598298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice.
    Araujo FG; Suzuki Y; Remington JS
    Eur J Clin Microbiol Infect Dis; 1996 May; 15(5):394-7. PubMed ID: 8793398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections.
    Li Y; Zeng YM; Lu YQ; Qin YY; Chen YK
    Medicine (Baltimore); 2020 May; 99(20):e20146. PubMed ID: 32443329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus.
    Richards FO; Kovacs JA; Luft BJ
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S49-56. PubMed ID: 8547512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
    Podzamczer D; Miró JM; Ferrer E; Gatell JM; Ramón JM; Ribera E; Sirera G; Cruceta A; Knobel H; Domingo P; Polo R; Leyes M; Cosin J; Fariñas MC; Arrizabalaga J; Martínez-Lacasa J; Gudiol F
    Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):89-95. PubMed ID: 10746493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
    Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N
    J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.
    Katlama C; De Wit S; O'Doherty E; Van Glabeke M; Clumeck N
    Clin Infect Dis; 1996 Feb; 22(2):268-75. PubMed ID: 8838183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994].
    Bossi P; Caumes E; Astagneau P; Li TS; Paris L; Mengual X; Katlama C; Bricaire F
    Rev Med Interne; 1998 May; 19(5):313-7. PubMed ID: 9775164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Antinori A; Murri R; Ammassari A; De Luca A; Linzalone A; Cingolani A; Damiano F; Maiuro G; Vecchiet J; Scoppettuolo G
    AIDS; 1995 Dec; 9(12):1343-50. PubMed ID: 8605054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
    Opravil M; Hirschel B; Lazzarin A; Heald A; Pechère M; Rüttimann S; Iten A; von Overbeck J; Oertle D; Praz G
    Clin Infect Dis; 1995 Mar; 20(3):531-41. PubMed ID: 7756472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group.
    Torre D; Casari S; Speranza F; Donisi A; Gregis G; Poggio A; Ranieri S; Orani A; Angarano G; Chiodo F; Fiori G; Carosi G
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1346-9. PubMed ID: 9624473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Clindamycin and Azithromycin as Alternative Treatment for Toxoplasma gondii Encephalitis.
    Shiojiri D; Kinai E; Teruya K; Kikuchi Y; Oka S
    Emerg Infect Dis; 2019 Apr; 25(4):841-843. PubMed ID: 30882331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis.
    Derouin F; Gérard L; Farinotti R; Maslo C; Leport C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):50-4. PubMed ID: 9732069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group.
    Leport C; Chêne G; Morlat P; Luft BJ; Rousseau F; Pueyo S; Hafner R; Miro J; Aubertin J; Salamon R; Vildé JL
    J Infect Dis; 1996 Jan; 173(1):91-7. PubMed ID: 8537688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The impact of the prevention of cerebral toxoplasmosis].
    Katlama C
    J Neuroradiol; 1995 Sep; 22(3):193-5. PubMed ID: 7472536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii.
    de Diego JA; Penin P; Arribas JR; Vázquez E; Vázquez JJ
    Folia Microbiol (Praha); 1996; 41(6):513-6. PubMed ID: 9131805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.
    Chirgwin K; Hafner R; Leport C; Remington J; Andersen J; Bosler EM; Roque C; Rajicic N; McAuliffe V; Morlat P; Jayaweera DT; Vilde JL; Luft BJ
    Clin Infect Dis; 2002 May; 34(9):1243-50. PubMed ID: 11941551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.